1. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, et al. (1999) Causal Pathways for Incident Lower-Extremity Ulcers in Patients with Diabetes from Two Settings. Diabetes Care 22(1): 157-162.
2. Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366(9498): 1736 -1743.
3. Fu X, Li X, Cheng B, Chen W, Sheng Z (2005) Engineered growth factors and cutaneous wound healing: Success and possible questions in the past 10 years. Wound Repair Regen 13(2): 122-130.
4. Martin P (1997) Wound healing-aiming for perfect skin regeneration. Science 276(5309): 75-81.
5. Galkowska H, Wojewodzka U, Olszewski WL (2006) Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound
6. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, et al. (2007) Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 170(4): 1178-1191.
25.Goren E Müller, Schiefelbein D, Gutwein P, Seitz O, et al. (2009) Akt1 controls insulin-driven VEGF biosynthesis from keratinocytes: implications for normal and diabetes-impaired skin repair in mice. J Invest Dermatol 129(3): 752-764.
7. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, et al. (2004) Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164(6): 1935- 1947.
8. Lima MH, Caricilli AM, de Abreu LL, Araújo EP, Pelegrinelli FF, et al. (2012) Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: A double-blind placebocontrolled clinical trial. PLoS One 7(5): e36974.
9. Hrynyk M, Neufeld RJ (2014) Insulin and wound healing. Burns 40(8): 1433-1446.